Cresilon

About:

Cresilon is a medical device company that produces and markets solutions for trauma care.

Twitter/X: cresilon

Top Investors: Paulson Investment Company, Dorm Room Fund, Innovating Capital

Description:

Cresilon is a medical device company that produces and markets solutions for trauma care. The company’s proprietary product, VETIGEL, is a hemostatic gel made from plant-derived materials to stop traumatic bleeding in seconds. It functions as a blood-clotting agent, and also as a scaffold to facilitate skin growth. Cresilon was co-founded by Joe Landolina and Isaac Miller in 2010 and is based in New York, United States.

Total Funding Amount:

$76.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Brooklyn, New York, United States

Founded Date:

2010-09-01

Contact Email:

info(AT)cresilon.com

Founders:

Isaac Miller, Joe Landolina

Number of Employees:

11-50

Last Funding Date:

2022-10-27

IPO Status:

Private

Industries: